XML 15 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 1,827 $ 1,975
Accounts receivables, net of allowance for credit losses of $117 million and $135 million as of September 30, 2020 and December 31, 2019 4,385 5,676
Inventories 4,516 4,422
Prepaid expenses 895 870
Other current assets 423 434
Assets held for sale 113 87
Total current assets 12,160 13,464
Deferred income taxes 509 386
Other non-current assets 822 591
Property, plant and equipment, net 6,152 6,436
Operating lease right-of-use assets 557 514
Identifiable intangible assets, net 9,308 11,232
Goodwill [1] 20,228 24,846
Total assets 49,737 57,470
Current liabilities:    
Short-term debt 2,106 2,345
Sales reserves and allowances 4,998 6,159
Accounts payables 1,716 1,718
Employee-related obligations 601 693
Accrued expenses 1,735 1,869
Other current liabilities 946 889
Total current liabilities 12,103 13,674
Long-term liabilities:    
Deferred income taxes 874 1,096
Other taxes and long-term liabilities 2,181 2,640
Senior notes and loans 23,515 24,562
Operating lease liabilities 472 435
Total long-term liabilities 27,042 28,733
Commitments and contingencies, see note 10  
Total liabilities 39,145 42,407
Teva shareholders' equity:    
Ordinary shares of NIS 0.10 par value per share; September 30, 2020 and December 31, 2019: authorized 2,495 million shares; issued 1,202 million shares and 1,198 million shares, respectively 57 56
Additional paid-in capital 27,403 27,312
Accumulated deficit (11,096) (6,956)
Accumulated other comprehensive loss (2,643) (2,312)
Treasury shares as of September 30, 2020 and December 31, 2019 — 106 million ordinary shares (4,128) (4,128)
Stockholders' equity attributable to Teva shareholders 9,593 13,972
Non-controlling interests 999 1,091
Total equity 10,592 15,063
Total liabilities and equity $ 49,737 $ 57,470
[1] Accumulated goodwill impairment as of September 30, 2020 and December 31, 2019 was approximately $25.6 billion and $21.0 million, respectively.